Skip to content

Antioxidant

SR-(METHIONYL S-RAINBOW TROUT OLIGOPEPTIDE-1 SH-POLYPEPTIDE-9 HEXAPEPTIDE-40)

77

Safety score · 0–100

Fine

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A 133-amino-acid recombinant fusion peptide from E. coli combining rainbow trout and human-mimicking peptide domains, intended for antioxidant, skin-protecting, and conditioning uses.

This methionyl-fusion peptide is assembled from three functional domains expressed in E. coli: rainbow trout s-Oligopeptide-1, sh-Polypeptide-9, and Hexapeptide-40. sh-Polypeptide-9 sequences in CosIng are commonly associated with growth-factor mimetics. The recombinant protein is characterised by its defined amino-acid sequence and the absence of post-translational modifications beyond possible disulphide bonding and glycosylation. The ingredient falls under the general provisions of Regulation (EU) 1223/2009 with no specific restrictions applied.

Function

ANTIOXIDANTHAIR CONDITIONINGSKIN PROTECTINGSKIN CONDITIONING - HUMECTANT

Skin benefits

  • Antioxidant capacity
  • Skin protecting and humectant activity
  • Hair conditioning support

Known concerns

  • E. coli endotoxin must be reduced to cosmetic-grade levels
  • Fish-derived allergen potential
  • Limited post-market safety data

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related antioxidants

Check your shelf

Find SR-(METHIONYL S-RAINBOW TROUT OLIGOPEPTIDE-1 SH-POLYPEPTIDE-9 HEXAPEPTIDE-40) in your products.

Scan any cosmetic product with LuxSense to see if it contains SR-(METHIONYL S-RAINBOW TROUT OLIGOPEPTIDE-1 SH-POLYPEPTIDE-9 HEXAPEPTIDE-40) and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.